Cargando…
BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity
Previously, we reported the in vitro growth inhibitory effect of diarylpentanoid BP-M345 on human cancer cells. Nevertheless, at that time, the cellular mechanism through which BP-M345 exerts its growth inhibitory effect remained to be explored. In the present work, we report its mechanism of action...
Autores principales: | Novais, Pedro, Silva, Patrícia M. A., Moreira, Joana, Palmeira, Andreia, Amorim, Isabel, Pinto, Madalena, Cidade, Honorina, Bousbaa, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659070/ https://www.ncbi.nlm.nih.gov/pubmed/34885726 http://dx.doi.org/10.3390/molecules26237139 |
Ejemplares similares
-
Structure–Activity Relationship Studies of Chalcones and Diarylpentanoids with Antitumor Activity: Potency and Selectivity Optimization
por: Moreira, Joana, et al.
Publicado: (2023) -
Bioactive Diarylpentanoids: Insights into the Biological Effects beyond Antitumor Activity and Structure–Activity Relationships
por: Moreira, Joana, et al.
Publicado: (2022) -
Discovery of a New Chalcone-Trimethoxycinnamide Hybrid with Antimitotic Effect: Design, Synthesis, and Structure—Activity Relationship Studies
por: Moreira, Joana, et al.
Publicado: (2023) -
Prenylated Chalcone 2 Acts as an Antimitotic Agent and Enhances the Chemosensitivity of Tumor Cells to Paclitaxel
por: Fonseca, Joana, et al.
Publicado: (2016) -
Second-Generation Antimitotics in Cancer Clinical Trials
por: Novais, Pedro, et al.
Publicado: (2021)